Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy

Status unconfirmed · Not applicable

Conditions studied: Liver Cancer

In brief

RATIONALE: Diagnostic procedures, such as contrast-enhanced CT scan and contrast-enhanced MRI, may help find liver cancer and find out how far the disease has spread. PURPOSE: This clinical trial is studying contrast-enhanced CT scan and contrast-enhanced MRI in diagnosing and staging liver cancer in patients with chronic liver disease.

Key facts

Study ID

NCT01082224

Run by

American College of Radiology Imaging Network

People needed

440

Starts

2010-12-01

Expected to finish

2023-12-01

Last updated by the study team

2023-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UAB Comprehensive Cancer Center — Birmingham, Alabama, United States
• Mayo Clinic Scottsdale — Scottsdale, Arizona, United States
• USC/Norris Comprehensive Cancer Center and Hospital — Los Angeles, California, United States
• Georgetown University Hospital — Washington D.C., District of Columbia, United States
• Lahey Clinic Medical Center - Burlington — Burlington, Massachusetts, United States
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• Washington University, St. Louis — St Louis, Missouri, United States
• Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
• The Methodist Hospital for Liver Disease and Transplant — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.